226 related articles for article (PubMed ID: 34709608)
1. A Method to Map Gene Essentiality of Human Pluripotent Stem Cells by Genome-Scale CRISPR Screens with Inducible Cas9.
Mair B; Aregger M; Tong AHY; Chan KSK; Moffat J
Methods Mol Biol; 2022; 2377():1-27. PubMed ID: 34709608
[TBL] [Abstract][Full Text] [Related]
2. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies.
Mair B; Tomic J; Masud SN; Tonge P; Weiss A; Usaj M; Tong AHY; Kwan JJ; Brown KR; Titus E; Atkins M; Chan KSK; Munsie L; Habsid A; Han H; Kennedy M; Cohen B; Keller G; Moffat J
Cell Rep; 2019 Apr; 27(2):599-615.e12. PubMed ID: 30970261
[TBL] [Abstract][Full Text] [Related]
3. Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes.
Ihry RJ; Salick MR; Ho DJ; Sondey M; Kommineni S; Paula S; Raymond J; Henry B; Frias E; Wang Q; Worringer KA; Ye C; Russ C; Reece-Hoyes JS; Altshuler RC; Randhawa R; Yang Z; McAllister G; Hoffman GR; Dolmetsch R; Kaykas A
Cell Rep; 2019 Apr; 27(2):616-630.e6. PubMed ID: 30970262
[TBL] [Abstract][Full Text] [Related]
4. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
[TBL] [Abstract][Full Text] [Related]
5. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.
Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A
Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062
[TBL] [Abstract][Full Text] [Related]
6. Protocol for genome-scale CRISPR screening in engineered lineage reporter hPSCs to study cell fate determination.
Zhou Z; Ma L; Zhang X
STAR Protoc; 2021 Jun; 2(2):100548. PubMed ID: 34095862
[No Abstract] [Full Text] [Related]
7. Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development.
Shi ZD; Soh CL; Zhu Z; Huangfu D
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28287608
[TBL] [Abstract][Full Text] [Related]
8. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
9. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.
Chang Y; Hellwarth PB; Randolph LN; Sun Y; Xing Y; Zhu W; Lian XL; Bao X
Biotechnol Bioeng; 2020 Jul; 117(7):2177-2186. PubMed ID: 32277708
[TBL] [Abstract][Full Text] [Related]
11. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.
Chen YH; Pruett-Miller SM
Stem Cell Res; 2018 Aug; 31():186-192. PubMed ID: 30099335
[TBL] [Abstract][Full Text] [Related]
12. Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.
Steyer B; Bu Q; Cory E; Jiang K; Duong S; Sinha D; Steltzer S; Gamm D; Chang Q; Saha K
Stem Cell Reports; 2018 Feb; 10(2):642-654. PubMed ID: 29307579
[TBL] [Abstract][Full Text] [Related]
13. Defining essential genes for human pluripotent stem cells by CRISPR-Cas9 screening in haploid cells.
Yilmaz A; Peretz M; Aharony A; Sagi I; Benvenisty N
Nat Cell Biol; 2018 May; 20(5):610-619. PubMed ID: 29662178
[TBL] [Abstract][Full Text] [Related]
14. Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.
Hongisto H; Ilmarinen T; Vattulainen M; Mikhailova A; Skottman H
Stem Cell Res Ther; 2017 Dec; 8(1):291. PubMed ID: 29284513
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
16. Manipulating and studying gene function in human pluripotent stem cell models.
Balmas E; Sozza F; Bottini S; Ratto ML; Savorè G; Becca S; Snijders KE; Bertero A
FEBS Lett; 2023 Sep; 597(18):2250-2287. PubMed ID: 37519013
[TBL] [Abstract][Full Text] [Related]
17. Feeder cells treated with ethanol can be used to maintain self-renewal and pluripotency of human pluripotent stem cells.
Ren Y; Zhang S; Liang Y; Gong Z; Cui Y; Song W
FEBS Open Bio; 2023 Feb; 13(2):279-292. PubMed ID: 36537760
[TBL] [Abstract][Full Text] [Related]
18. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
Cells; 2020 May; 9(5):. PubMed ID: 32466123
[TBL] [Abstract][Full Text] [Related]
19. Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency.
Park TS; Zimmerlin L; Evans-Moses R; Zambidis ET
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939183
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
